Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Fmcg | Small Cap
Health Score : 5.31Emami Ltd, an FMCG company, exhibits a mixed financial performance. The company demonstrates strong solvency, driven by a high equity ratio and no debt, suggesting a stable financial structure. Profitability is robust, supported by high returns on capital employed and assets. However, liquidity is poor, with all key liquidity ratios at zero. Growth is moderate, with strong operating profit, EPS, and asset growth, but revenue and net income growth are lacking. Coverage ratios are strong for interest but weak for equity dividends. Financial ratios present a mixed picture, with solid dividend per share but low adjusted and cash earnings per share. Efficiency ratios are generally weak. Overall, Emami showcases financial stability and profitability, but needs to address its liquidity and efficiency to ensure sustained growth.
Health Score : 5.31Emami Ltd, an FMCG company, exhibits a mixed financial performance. The company demonstrates strong solvency, driven by a high equity ratio and no debt, suggesting a stable financial structure. Profitability is robust, supported by high returns on capital employed and assets. However, liquidity is poor, with all key liquidity ratios at zero. Growth is moderate, with strong operating profit, EPS, and asset growth, but revenue and net income growth are lacking. Coverage ratios are strong for interest but weak for equity dividends. Financial ratios present a mixed picture, with solid dividend per share but low adjusted and cash earnings per share. Efficiency ratios are generally weak. Overall, Emami showcases financial stability and profitability, but needs to address its liquidity and efficiency to ensure sustained growth.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
19.54
Industry Median
30.52
Small Cap Median
25.78
P/E RATIO
21.21
P/B RATIO
5.62
Industry Median
5.59
Small Cap Median
3.33
P/S RATIO
4.28
Industry Median
4.28
Small Cap Median
2.12
Others
PEG RATIO
0.00
EV/EBITDA RATIO
15.29
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹376.65 as on Sep 1, 2026.
Growth Score : 6.00The growth of Emami Ltd is mixed. The revenue and net income growth rates are at zero, indicating a lack of top-line expansion. However, the operating profit, EPS, and asset growth rates are positive, indicating growth from core operations and increasing asset base. The company should focus on strategies to boost revenue and net income.
Revenue Growth RatePoor
Operating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 10.79 | 6.7 | 5.05 | 6.46 | -0.76 |
| Operating Profit Growth Rate | 6.59 | -8.85 | 10.64 | 7.19 | -5.33 |
| Earnings Per Share (EPS) Growth | 85.92 | -23.76 | 14.34 | 11.46 | -3.9 |
| Asset Growth Rate | 21.03 | 1.51 | 5.59 | 7.83 | 8.82 |
| Net Income Growth Rate | 83.96 | -25.09 | 15.47 | 10.91 | -3.49 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Jyothy Labs Ltd | 7.95 | 20.30 | Neutral | 500.00 | 7.74 | 370.00 |
| 2 | Honasa Consumer Ltd | 5.69 | 76.99 | Neutral | 236.00 | 5.85 | 200.00 |
| 3 | Emami Ltd | 5.31 | 21.21 | Neutral | 960.00 | 19.28 | 775.00 |
| 4 | Gillette India Ltd | 3.51 | 36.95 | Neutral | 961.00 | 205.02 | 668.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
No Stock News Available at This Moment.
Emami Ltd. is a leading Indian Fast Moving Consumer Goods (FMCG) company, specializing in manufacturing and marketing a diverse portfolio of personal care and healthcare products. With iconic brands like BoroPlus, Zandu, and Navratna, the company holds strong market positions across various categories in domestic and international markets.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Emami Ltd's P/E ratio (TTM) is 19.54, compared to the industry median of 30.52 and large cap median of 25.78.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Emami Ltd's P/B ratio is 5.62, compared to the industry median of 5.59 and large cap median of 3.33.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Emami Ltd's P/S ratio is 4.28, compared to the industry median of 4.28 and large cap median of 2.12.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Emami Ltd's PEG ratio is 1.85.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Emami Ltd's EV/EBITDA ratio is 15.29.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Emami Ltd's ROE is 26.50%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Emami Ltd's ROA is 25.03%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Emami Ltd's ROCE is 30%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Emami Ltd's operating margin is 25.40%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Emami Ltd's net margin is 20.50%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Emami Ltd's current ratio is 2.42.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Emami Ltd's debt-to-equity ratio is 0.01.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Emami Ltd's interest coverage ratio is 77.91.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Emami Ltd's DPS is ₹6.04.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Emami Ltd's EPS is -3.90.
(Source line: "Ratios as of 23 Oct 2026, based on last traded price of ₹376.65. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1974
Headquarters: Kolkata, West Bengal
Core Offerings: Healthcare & Pain Management, Skincare, Hair Oils, Men's Grooming, Ayurvedic products
Stock Listing: NSE (EMAMILTD), BSE (531162)
Promoter: Emami Group (Agarwal and Goenka families)
Founded in 1974 by Mr. R.S. Agarwal and Mr. R.S. Goenka in Kolkata, Emami started as a cosmetic manufacturing unit. The company was incorporated as Emami Limited in 1994. Over the decades, it expanded its product portfolio through organic growth and strategic acquisitions, notably acquiring Zandu Pharmaceutical Works Ltd. in 2008, significantly strengthening its presence in the healthcare segment. Emami has continued to grow its brand presence and market share, including recent acquisitions in men's grooming and professional salon products.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Healthcare & Pain Management | 37.2% | Operating Profit |
| Skincare | 33.9% | Operating Profit |
| Hair Care | 22.8% | Operating Profit |
| Others | 5.7% | Operating Profit |
Healthcare & Pain Management: Comprises well-known brands like Zandu Balm, Zandu Chyavanprash, Fast Relief, and Mentho Plus. Focuses on traditional ayurvedic remedies and modern pain relief solutions.
Skincare: Includes flagship brands such as BoroPlus (antiseptic cream, lotions) and Fair and Handsome (men's fairness cream). Caters to daily skincare, grooming, and antiseptic needs.
Hair Care: Features iconic brands like Navratna (cooling oil) and Kesh King (ayurvedic hair oil and shampoo). Addresses various hair and scalp related concerns from stress relief to hair fall control.
Mr. Mohan Goenka - Vice Chairman and Whole-Time Director: Oversees various business functions, including marketing, sales, and supply chain, driving strategic growth initiatives. Mr. Harsha V. Agarwal - Vice Chairman and Whole-Time Director: Focuses on finance, M&A, HR, and digital transformation, contributing to corporate strategy and expansion. Mr. Vivek Agrawal - CEO: Responsible for the overall business operations, strategic direction, and performance of the company.
Emami International Ltd.
Emami Bangladesh Ltd.
Emami Overseas FZE
PharmaDerm Laboratories Ltd.
Emami Asia Pacific PTE Ltd.
2008: Acquired Zandu Pharmaceutical Works Ltd., significantly expanding its healthcare portfolio. 2019: Acquired a majority stake in Brillare Science Pvt. Ltd., venturing into the professional salon products segment. 2022: Acquired a strategic stake in Helios Lifestyle Pvt Ltd (The Man Company), strengthening its men's grooming offerings.
The Emami Ltd share price today is ₹376.65 on NSE (EMAMILTD), as of 23 Oct 2026.
As of 23 Oct 2026, Emami Ltd share price is ₹376.65, with previous close ₹376.65. Today's range is ₹376.65 to ₹376.65. The 52-week range is ₹361.60 to ₹540.
As of today, Emami Ltd's market cap is ₹16,180.88 crore (Mid Cap).
Emami Ltd's current P/E ratio is 19.54, compared to the FMCG sector average of 58.
Emami Ltd's current P/B ratio is 5.62.
Emami Ltd's current dividend yield is 1.60%. Last dividend of ₹4.00 per share was declared on 03-Aug-2023.
Emami Ltd's EPS (TTM) is ₹-3.90.
Emami Ltd. is a leading Indian Fast Moving Consumer Goods (FMCG) company, specializing in manufacturing and marketing a diverse portfolio of personal care and healthcare products. With iconic brands like BoroPlus, Zandu, and Navratna, the company holds strong market positions across various categories in domestic and international markets.
Emami Ltd is promoted by Emami Group (Agarwal and Goenka families), holding 54.84% as of 23 Oct 2026.
Emami Ltd is listed on NSE (EMAMILTD) and BSE (531162). Its next quarterly results are expected on August 2024.